POTENTIAL BIOMARKERS OF VASCULAR ANOMALIES RELATED WITH SIROLIMUS TREATMENT

被引：0
|
作者：
Ozeki, Michio [1 ]
Hayashi, Daichi [1 ]
Yasue, Shiho [1 ]
Endo, Saori [1 ]
Fumino, Shigehisa [2 ]
Furukawa, Taizo [2 ]
Takemoto, Junkichi [3 ]
Tajiri, Tatsuro [3 ]
Ohnishi, Hidenori [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu, Japan
[2] Kyoto Prefectural Univ Med, Dept Pediat Surg, Kyoto, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Pediat Surg, Fukuoka, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS6-3
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Immunologic Effects of Sirolimus in Patients with Vascular Anomalies
    Nozawa, Akifumi
    Ozeki, Michio
    Yasue, Shiho
    Endo, Saori
    Kawamoto, Norio
    Maekawa, Takanobu
    Fumino, Shigehisa
    Furukawa, Taizo
    Souzaki, Ryota
    Onishi, Hidenori
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [22] Recurrence and restart of sirolimus in vascular anomalies after withdrawal
    Liu, Hongyuan
    Yang, Xi
    Jia, Hechen
    Hu, Li
    Xu, Zian
    Chen, Hui
    Lin, Xiaoxi
    JOURNAL OF DERMATOLOGY, 2023, 50 (04): : E119 - E120
  • [23] A prospective multicenter study of sirolimus for complicated vascular anomalies
    Ji, Yi
    Chen, Siyuan
    Yang, Kaiying
    Zhou, Jiangyuan
    Zhang, Xuepeng
    Jiang, Xian
    Xu, Xuewen
    Lu, Guoyan
    Qiu, Liqing
    Kong, Feiteng
    Zhang, Yongbo
    JOURNAL OF VASCULAR SURGERY, 2021, 74 (05) : 1673 - +
  • [24] No Association of Sirolimus with Wound Complications in Children With Vascular Anomalies
    Mehl, Steven C.
    Whitlock, Richard S.
    Ortega, Rachel M.
    Creden, Sam
    Iacobas, Ionela
    Maricevich, Renata S.
    Rosenberg, Tara L.
    Rialon, Kristy L.
    JOURNAL OF PEDIATRIC SURGERY, 2023, 58 (08) : 1555 - 1559
  • [25] OPTIMIZATION OF LABORATORY MONITORING FOR SIROLIMUS IN THE MANAGEMENT OF VASCULAR ANOMALIES
    Lad, Raina
    Chae, Jooyeon
    Mahajan, Priya
    Margolin, Judith
    Iacobas, Ionela
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S100 - S101
  • [26] Safety and efficacy of sirolimus in patients with refractory vascular anomalies
    Youssef, Ahmed Abdelhaseeb
    Mostafa, Mohamed S.
    Fawzy, Ahmed
    Elzeneini, Wael M. A.
    Aly, Mohamed M. D.
    Soliman, Mohamed H.
    Abdel-Latif, Mohammed
    Abdelsattar, Mohamed
    Ragab, Eman
    Abdel-Kader, Hesham M.
    EGYPTIAN JOURNAL OF SURGERY, 2019, 38 (01): : 127 - 130
  • [27] Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series
    Karastaneva, Anna
    Gasparella, Paolo
    Tschauner, Sebastian
    Crazzolara, Roman
    Kropshofer, Gabriele
    Modl, Manfred
    Pfleger, Andreas
    Burmas, Ante
    Pocivalnik, Mirjam
    Ulreich, Raphael
    Zenz, Werner
    Schwinger, Wolfgang
    Beqo, Besiana P.
    Urban, Christian
    Haxhija, Emir Q.
    Lackner, Herwig
    Benesch, Martin
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [28] Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review
    Sandbank, Shira
    Molho-Pessach, Vered
    Farkas, Adam
    Barzilai, Aviv
    Greenberger, Shoshana
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (11) : 990 - 996
  • [29] Sirolimus for vascular anomalies in the first year of life: a systematic review
    Cavazos, Rebeca
    Patil, Monika S.
    Gowda, Sharada H.
    Iacobas, Ionela
    Rosenberg, Tara
    Fernandes, Caraciolo J.
    Pammi, Mohan
    JOURNAL OF PERINATOLOGY, 2024, 44 (08) : 1087 - 1097
  • [30] Sirolimus for vascular anomalies associated with PTEN hamartoma tumor syndrome
    Zabeida, Alexandra
    Brzezinski, Jack J.
    Wasserman, Jonathan D.
    Cytrynbaum, Cheryl
    Weksberg, Rosanna
    Zwicker, Kelley
    Zbuk, Kevin
    Gasparetto, Alessandro
    Willis, Laura
    Fantauzzi, Michelle
    Carcao, Manuel
    PEDIATRIC BLOOD & CANCER, 2024,
12345